ABO Blood Group System PDF
ABO Blood Group System PDF
ABO Blood Group System PDF
http://www.nobelpreis.org/castellano/medizin/images/landsteiner.jpg
Why is it important?
ABO ANTIGENS
ABO INHERITANCE
In 1924, Bernstein described the theory for the inheritance of ABO blood groups Codominant in expression Genotypes: Phenotypes:
Location
The presence or absence of the ABH antigens on the red blood cell membrane is controlled by the The presence or absence of the ABH antigens in secretions is indirectly controlled by the
H Antigen
The H gene codes for an enzyme that adds the sugar fucose to the terminal sugar of a
H antigen
The H antigen is the foundation upon which A and B antigens are built A and B genes code for enzymes that add an immunodominant sugar to the H antigen ________________________are present at the terminal ends of the chains and confer the ABO antigen specificity
A and B Antigen
The A gene codes for an enzyme (transferase) that adds _______________________to the terminal sugar of the H antigen
N-acetylgalactosaminyltransferase
The B gene codes for an enzyme that adds ________________to the terminal sugar of the H antigen
D-galactosyltransferase
Fucose
Fucose
Genetics
The _____________ is found on the RBC when you have the Hh or HH genotype, but NOT from the hh genotype The _____________is found on the RBC when you have the Hh, HH, and A/A, A/O, or A/B genotypes
The _____________is found on the RBC when you have the Hh, HH, and B/B, B/O, or A/B genotypes
H antigen
Certain blood types possess more H antigen than others:
Greatest amount of H
Least amount of H
Secretor Status
The secretor gene consists of 2 alleles (Se and se) The Se gene is responsible for the
If the Se allele is inherited as SeSe or Sese, the person is called a 80% of the population are secretors
Secretors
Secretors express soluble forms of the H antigen in secretions that can then be Individuals who inherit the sese gene are called
The se allele is an amorph (nothing expressed) sese individuals do not convert antigen precursors to H antigen and has neither soluble H antigen nor soluble A or B antigens in body fluids
B antigen
ABO Group
Secretors (SeSe or Sese):
A B
ABH Substances
A
+++ 0
B
0 +++
H
+ +
O
AB Non-secretors (sese): A, B, O, and AB
0
+++
0
+++
+++
+
RBC antigens are only synthesized on type Secreted substances are primarily 2 precursor chains synthesized on type 1 precursor chains Type 2 chain refers to a beta1 4 linkage in which the number one carbon of the galactose is attached to the number three carbon of the N-acetylglucosamine sugar of the precursor substance Enzyme produced by the H gene (-2-Lfucosyltransferase)acts primarily on type 2 chains, which are prevalent on the RBC membrane Type 1 chain refers to a beta 1 3 linkage in which the number one carbon of the galactose is attached to the number three carbon of the N-acetylglucosamine sugar of the precursor substance Enzyme produced by the Se gene (-2-Lfucosyltransferase) preferentially acts on type 1 chains in secretory tissues
Lewis (Le)
The Lewis Blood Group System is mentioned here because it is related to secretor status Lewis antigens are plasma antigens formed by tissues and are released into plasma where they adsorb onto the RBCs (they are not an integral part of the RBC membrane) Consists of 2 antigens Lea Leb
Lewis
Lea and Leb are a single gene (Le) and its amorph (le) Lea is a precursor to Leb The Le gene codes for a transferase, which attaches L-fucose to the precursor chain to form the Lea antigen (designated Le(a+b-) If the H and Se genes are inherited, the Lea is converted to Leb and is designated Le(a-b+) In childhood, both may be on the RBC, Le(a+b+) If a person is lele, they will have no Lewis antigens in plasma or on red blood cells
ABO Subgroups
ABO subgroups differ in the amount of antigen present on the red blood cell membrane Subgroups have less antigen Subgroups are the result of less effective enzymes. They are not as efficient in converting H antigens to A or B antigens (fewer antigens are present on the RBC) Subgroups of A are more common than subgroups of B
Subgroups of A
The 2 principle subgroups of A are: A1 and A2
A2 Phenotype
Why is the A2 phenotype important? A2 and A2B individuals may produce an anti-A1 This may cause discrepancies when a crossmatch is done (incompatibility) Whats the difference between the A1 and A2 antigen?
A1 and A2 Subgroups*
Anti-A Anti-A1 Anti-H antisera antisera lectin ABO antibodies in serum # of antigen sites per RBC
A1 A2
4+ 4+
4+ 0
0 3+
Other A subgroups
There are other additional subgroups of A Aint (intermediate), A3, Ax, Am, Aend, Ael, Abantu A3 red cells cause mixed field agglutination when polyclonal anti-A or anti-A,B is used Mixed field agglutination appears as small agglutinates with a background of unagglutinated RBCs They may contain anti-A1
B Subgroups
B subgroups occur less than A subgroups B subgroups are differentiated by the type of reaction with anti-B, anti-A,B, and anti-H B3, Bx, Bm, and Bel
H deficient phenotypes
Basic Concepts
Rare phenotypes in which the RBCs are completely devoid of H antigens or that have small amounts of H antigen present Three categories: 1) Category 1:
2) Category 2:
3) Category 3:
CLASSIFICATION
Glycosyltransferase
Antibodies in serum
Category 1 Oh , Oh B, O h A, OhAB
hh sese
None detectable
None detectable
A and/or B hh sese
A and/or B in Weak A/B None serum and Residual H detectable RBC stroma when A or B immunodomi nant sugar is removed with appropriate enzyme A and/or B in Weak A/B serum/ and H RBCs, H in serum (weak) H substance (normal amounts) A/B (all normal
Anti-H, AntiA/Anti-B
Category 3 Se O h O, O h A , O h B , OhAB
Weak IH Anti-A/anti-B
ABO DISCREPANCIES
Group I Group II Group III Group IV
GROUP I DISCREPANCIES
Unexpected reactions in reverse grouping due to weakly reacting or missing antibodies More common than most of the other groups Suspected when reaction in the serum grouping is weak or missing Reason: Patient has depressed antibody production or cannot produce ABO antibodies Rare group I discrepancies: Chimerism: presence of two cell populations in a single individual
GROUP I DISCREPANCIES
Some of the more common populations with discrepancies in this group are:
Newborns Elderly patients Patients with leukemias demonstrating hypogammaglobulinemia or lymphomas Patients using immunosuppressive drugs that yield hypogammaglobulinemia Patients with congenital agammaglobulinemia or immunodeficiency diseases Patients with bone marrow transplantations Patients whose existing ABO antibodies may have been diluted by plasma transfusion or exchange ABO subgroups
GROUP II DISCREPANCIES
Unexpected reactions in the forward grouping due to weakly reacting or missing antigens Least frequently encountered Some of the causes are:
Subgroup of A (or B) may be present Leukemias may yield weakened A or B antigens
Hodgkins disease has been reported in some cases to mimic the depression of antigens found in leukemia
Acquired B phenomenon is most often associated with diseases of the digestive tract ( cancer of the colon)
GROUP II DISCREPANCIES
Rare Group II discrepancies
Excess amounts of Blood group-specific soluble (BGSS) substances present in the plasma in association with certain diseases such as carcinoma of the stomach and pancreas Antibodies to low-incidence antigens in reagent anti-A or anti-B Chimerism
GROUP IV DISCREPANCIES
Between forward and reverse groupings due to miscellaneous problems and have the following :
Cold reactive autoantibodies in which RBCs are so heavily coated with antibody that they spontaneously agglutinate, independent of the specificity of the reagent antibody Patient has circulating RBCs of more than one ABO group due to RBC transfusion or marrow transplant Unexpected ABO isoagglutinins Unexpected non-ABO alloantibodies
GROUP IV DISCREPANCIES
Rare Group IV discrepancies
Antibodies other than anti-A or anti-B may react to form ag-ab complexes that may then adsorb onto patients RBCs Some individuals have antibodies against acriflavin in their serum
Pxs ab combines with the dye and attaches to the pxs rbcs, resulting in agglutination in the forward grouping
Landsteiners Rule:
Normal, Healthy individuals possess ABO antibodies to the ABO antigen absent from their RBCs
ABO
Remember:
The ABO Blood Group System does NOT require the presence of a foreign red blood cell for the production of ABO antibodies ABO antibodies are non-red blood cell stimulated probably from environmental exposure and are referred to as expected antibodies
ABO antibodies
group A serum contains anti-B group B serum contains anti-A group AB serum contains no antibodies group O serum contains anti-A, anti-B, and anti-A,B
Anti-A1
Group O and B individuals contain anti-A in their serum However, the anti-A can be separated into different components: anti-A and anti-A1
Anti-A,B
Found in the serum of group O individuals Reacts with A, B, and AB cells Predominately IgG, with small portions being IgM Anti-A,B is one antibody, it is not a mixture of anti-A and anti-B antibodies
ABO antibodies
Activate complement React at room temperature or colder IgM is the predominant antibody in Group A and Group B individuals
ABO Antibodies
Usually present within the first 3-6 months of life Stable by ages 5-6 years Decline in older age Newborns may passively acquire maternal antibodies (IgG crosses placenta) Reverse grouping (with serum) should not be performed on newborns or cord blood
Nature of antibodies
Non-red blood cell stimulated (previously discussed) ABO antibodies Red blood cell stimulated Antibodies formed as a result of transfusion, etc Usually IgG Active at 37C Can occur in group O (may occur in group A or B) These antibodies also occur in the other Blood Group Systems
Laboratory Testing:
ABO typing
58
B O
AB
B None
A and B
A A and B
None
anti-A 1 0
anti-B 0
A cells +
B cells +
ABO group O
2
3
+
0
0
+
0
+
+
0
A
B
AB
Pathologic fluids
Pleural Peritoneal Pericardial Ovarian cyst
Group O
Generally the most common blood group Genotype: OO Antigen: H Antibodies: anti-A, anti-B, and anti-A,B Antibodies are naturally occurring and very strong Anti-A,B (mostly IgG) may cross placenta to cause HDFN
Group A
Genotype: Antigen: Antibodies: A subgroups
Group B
Genotype: Antigen: Antibodies: B subgroups: Not important
Group AB
Genotype: Antigen: Antibodies: B subgroups: Not important A2B:
ABO Testing
Cell typing (forward grouping) to determine antigen types on RBCs Serum/plasma typing (reverse grouping or backtyping) to determine type of antibody in serum: Note the opposite reactions If the forward reactions are opposite of reverse, an ABO discrepancy is not present.
Forward Grouping
Reagent: Monoclonal antibody Highly specific IgM Expected 3+- to 4+ reaction 1 drop Anti-A=Blue; anti-B=Yellow (Acroflavin dye) A and B antigens on patient red cells are agglutinated by known sera (anti-A, anti-B)
Step 4: Add one drop of 2-5% suspension of patient RBC to each tube.
80
Back Typing
To determine what antibodies are present in patients plasma.
Antigen Problems
Lack of expected antigens
Antibody problems
Lack of expected antibodies
A Subgroups
A1 A2 A3 Ax Aend Am etc
A1 vs A2 Phenotypes
Blood Group A1 (80%) A2 (20%) Anti-A + + Anti-A1 lectin + 0
A1vs A2 Phenotypes
Quantitative differences:
B Subgroups
Very rare and are less frequent than A subgroups. B subgroups demonstrate variations in the strength of the reaction using antiB and anti-A,B
Acquired B phenotype
Occurs in type A individuals with:
Bacteria deacetylate group A sugar (GalNAc); remaining galactosamine crossreacts with reagent anti-B.
Acquired B phenotype
Acquired B phenotype
AB forward (with weak reactions with reagent anti-B) A reverse Reaction with anti-B is negative, if:
Reverse
A1 cells B cells Interp
4+
1-2+
AB
4+
AB
Antigens on rbcs
A B A,B None
Antibodies in Plasma
Anti-B Anti-A None Anti-A, Anti-B